NeuroSense Therapeutics L... (NRSN)

AI Score

Unlock

1.00

0.00 (0.00%)

At close: Apr 25, 2025, 3:59 PM

1.00

-0.01%

After-hours: Apr 25, 2025, 07:54 PM EDT

NeuroSense Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-9.9M	-11.42M	-12.21M	-12.65M	-13.3M	-13.39M	-13.82M	-13.93M	-13.55M	-11.82M	-9.38M	-6.74M	-5.59M	-5.06M	-5.3M	-4.67M	-2.89M	-1.77M	-650K	-325K
Interest Income	2.17M	2.17M	5.87M	3.83M	3.89M	3.89M	535K	541K	1.05M	1.05M	716K	583K	11K	11K	11K	n/a	n/a	n/a	n/a	n/a
Pretax Income	-10.21M	-11.36M	-8.43M	-12.79M	-11.28M	-11.48M	-15.26M	-13.51M	-12.34M	-9.29M	-7.18M	-4.63M	-4.04M	-5.04M	-5.26M	-4.64M	-2.83M	-1.73M	-622K	-311K
Net Income	-10.21M	-11.36M	-8.43M	-12.79M	-11.22M	-11.24M	-14.69M	-12.8M	-11.11M	-8.24M	-6.47M	-4.06M	-4.04M	-5.04M	-5.26M	-4.64M	-2.83M	-1.73M	-622K	-311K
Selling & General & Admin	4.2M	4.85M	5.17M	5.28M	5.71M	6.22M	6.56M	6.71M	7.14M	6.9M	5.65M	4.38M	2.5M	1.04M	822K	427K	393K	254.5K	116K	58K
Research & Development	5.7M	6.57M	7.03M	7.37M	7.59M	7.17M	7.25M	7.22M	6.42M	4.92M	3.73M	2.36M	3.08M	4.02M	4.48M	4.25M	2.5M	1.51M	534K	267K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.9M	11.42M	12.21M	12.65M	13.3M	13.39M	13.82M	13.93M	13.55M	11.82M	9.38M	6.74M	5.59M	5.04M	5.27M	4.63M	2.83M	1.73M	622K	311K
Interest Expense	2.41M	2.41M	4.61M	6.5M	4.4M	4.4M	2.21M	355K	68K	68K	58K	23K	13K	13K	13K	13K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.9M	11.42M	12.21M	12.65M	13.3M	13.39M	13.82M	13.93M	13.55M	11.82M	9.38M	6.74M	5.59M	5.04M	5.27M	4.63M	2.83M	1.73M	622K	311K
Income Tax Expense	-43.28K	-43.28K	5.88M	3.71M	3.69M	3.51M	-2.75M	-717K	-1.23M	-1.05M	-728.5K	-574.25K	-3K	750.00	25.5K	29.25K	44K	44K	28K	14K
Shares Outstanding (Basic)	19.21M	19.21M	18.06M	15.41M	15.38M	13.62M	13.62M	11.78M	11.78M	11.59M	11.28M	10.99M	10.94M	10.77M	10.94M	10.94M	5.58M	5.58M	5.45M	5.45M
Shares Outstanding (Diluted)	19.21M	19.21M	18.06M	15.41M	15.38M	13.62M	13.62M	11.78M	11.78M	11.59M	11.28M	11.31M	10.94M	10.77M	10.94M	10.94M	5.58M	5.58M	5.45M	5.45M
EPS (Basic)	-0.6	-0.7	-0.53	-0.86	-0.83	-0.89	-1.18	-1.1	-0.97	-0.73	-0.58	-0.37	-0.37	-0.56	-0.67	-0.65	-0.51	-0.31	-0.11	-0.06
EPS (Diluted)	-0.6	-0.7	-0.53	-0.86	-0.83	-0.89	-1.18	-1.1	-0.97	-0.73	-0.58	-0.37	-0.37	-0.56	-0.67	-0.65	-0.51	-0.31	-0.11	-0.06
EBITDA	-9.9M	-13.28M	-10.38M	-12.87M	-13.46M	-11.46M	-15.24M	-13.16M	-12.27M	-10.77M	-8.66M	-6.17M	-5.58M	-5.06M	-4.16M	-3.2M	-1.07M	44K	28K	14K
EBIT	-9.9M	-13.28M	-8.19M	-10.68M	-11.27M	-9.32M	-15.29M	-13.21M	-12.32M	-10.77M	-8.67M	-6.17M	-5.59M	-3.94M	-3.05M	-2.11M	n/a	n/a	n/a	n/a
Depreciation & Amortization	5.25K	10.5K	13.5K	37K	34.75K	32.5K	30.25K	27.25K	25K	22.75K	22.75K	3K	3K	3K	1.12M	1.45M	1.77M	1.77M	650K	325K